These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

939 related items for PubMed ID: 20299059

  • 1. Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients.
    Tilki D, Reich O, Svatek RS, Karakiewicz PI, Kassouf W, Novara G, Ficarra V, Chade DC, Fritsche HM, Gerwens N, Izawa JI, Lerner SP, Schoenberg M, Stief CG, Skinner E, Lotan Y, Sagalowsky AI, Shariat SF.
    J Urol; 2010 May; 183(5):1757-63. PubMed ID: 20299059
    [Abstract] [Full Text] [Related]

  • 2. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AI, Schoenberg MP, Lerner SP.
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [Abstract] [Full Text] [Related]

  • 3. Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients.
    Tilki D, Svatek RS, Novara G, Seitz M, Godoy G, Karakiewicz PI, Kassouf W, Fradet Y, Fritsche HM, Sonpavde G, Izawa JI, Ficarra V, Lerner SP, Schoenberg M, Stief CG, Dinney CP, Skinner E, Lotan Y, Sagalowsky AI, Reich O, Shariat SF.
    J Urol; 2010 Sep; 184(3):888-94. PubMed ID: 20643448
    [Abstract] [Full Text] [Related]

  • 4. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ, Stein JP, Cai J, Miranda G, Groshen S, Skinner DG.
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [Abstract] [Full Text] [Related]

  • 5. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA, Kavanagh K, Yossepowitch O, Kaag M, Olgac S, Donat M, Herr HW.
    J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [Abstract] [Full Text] [Related]

  • 6. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E, Iborra I, Rubio J, Casanova J, Almenar S.
    BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
    [Abstract] [Full Text] [Related]

  • 7. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy.
    Shariat SF, Palapattu GS, Karakiewicz PI, Rogers CG, Vazina A, Bastian PJ, Schoenberg MP, Lerner SP, Sagalowsky AI, Lotan Y.
    Eur Urol; 2007 Jan; 51(1):152-60. PubMed ID: 17011114
    [Abstract] [Full Text] [Related]

  • 8. Outcomes in patients with pathological carcinoma in situ only disease at radical cystectomy.
    Hassan JM, Cookson MS, Smith JA, Johnson DL, Chang SS.
    J Urol; 2004 Sep; 172(3):882-4. PubMed ID: 15310989
    [Abstract] [Full Text] [Related]

  • 9. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K, Kawakami S, Fujii Y, Sakura M, Masuda H, Kihara K.
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [Abstract] [Full Text] [Related]

  • 10. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.
    Cho KS, Seo HK, Joung JY, Park WS, Ro JY, Han KS, Chung J, Lee KH.
    J Urol; 2009 Dec; 182(6):2625-30. PubMed ID: 19836779
    [Abstract] [Full Text] [Related]

  • 11. [Analysis of 34 cases of infiltrating carcinoma of the bladder treated exclusively with partial cystectomy (part 1)].
    Escudero Barrilero A, Fernández Fernández E, Jiménez Cidre M, Maganto Pavón E, Mayayo Dehesa T, Rodríguez Rodríguez R, Galvis San Juan F, Burgos Revilla FJ.
    Arch Esp Urol; 1996 May; 49(4):349-64. PubMed ID: 8754191
    [Abstract] [Full Text] [Related]

  • 12. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K, Poulsen AL.
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [Abstract] [Full Text] [Related]

  • 13. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
    Huguet J, Crego M, Sabaté S, Salvador J, Palou J, Villavicencio H.
    Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
    [Abstract] [Full Text] [Related]

  • 14. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
    Lotan Y, Gupta A, Shariat SF, Palapattu GS, Vazina A, Karakiewicz PI, Bastian PJ, Rogers CG, Amiel G, Perotte P, Schoenberg MP, Lerner SP, Sagalowsky AI.
    J Clin Oncol; 2005 Sep 20; 23(27):6533-9. PubMed ID: 16116151
    [Abstract] [Full Text] [Related]

  • 15. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
    Kunju LP, You L, Zhang Y, Daignault S, Montie JE, Lee CT.
    J Urol; 2008 Nov 20; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of lymphovascular invasion in bladder cancer in patients treated with radical cystectomy.
    Palmieri F, Brunocilla E, Bertaccini A, Guidi M, Pernetti R, Morselli-Labate AM, Martorana G.
    Anticancer Res; 2010 Jul 20; 30(7):2973-6. PubMed ID: 20683041
    [Abstract] [Full Text] [Related]

  • 17. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
    Streeper NM, Simons CM, Konety BR, Muirhead DM, Williams RD, O'Donnell MA, Joudi FN.
    BJU Int; 2009 Feb 20; 103(4):475-9. PubMed ID: 18990174
    [Abstract] [Full Text] [Related]

  • 18. Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection.
    Holzbeierlein JM, Lopez-Corona E, Bochner BH, Herr HW, Donat SM, Russo P, Dalbagni G, Sogani PC.
    J Urol; 2004 Sep 20; 172(3):878-81. PubMed ID: 15310988
    [Abstract] [Full Text] [Related]

  • 19. Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy.
    Dutta SC, Smith JA, Shappell SB, Coffey CS, Chang SS, Cookson MS.
    J Urol; 2001 Aug 20; 166(2):490-3. PubMed ID: 11458053
    [Abstract] [Full Text] [Related]

  • 20. Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy.
    Quek ML, Stein JP, Nichols PW, Cai J, Miranda G, Groshen S, Daneshmand S, Skinner EC, Skinner DG.
    J Urol; 2005 Jul 20; 174(1):103-6. PubMed ID: 15947587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.